We only have this paper's title and publication details.
Read it at the sourceRandomized trial evaluates lipid parameters and gut microbiota in dyslipidemia, suggesting safety and efficacy of Trikatu.
No takes yet. Share an insight, caveat, or question.
Khanduri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: